Please assess the completion status of the following clinical trial:

Trial Title: Trial to Evaluate the Safety and Immunogenicity of Multivalent Pneumococcal Vaccines in Japanese Adults 18 to 49 Years of Age

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE1
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Male or female Japanese subjects 18 to 49 years of age, defined as Japanese born in Japan, with both parents and 4 grandparents who wer born in Japan (family tree by history), and who have not lived outside of Japan for more than 5 years total (confirmed by passport or interview)~Exclusion Criteria:~* Participation in other studies involving investigational drug(s), investigational vaccines, or investigational medical devised within 28 days prior to study entry and/or during study participation. Participation in purely observational studies is acceptable.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 49 Years
- Healthy Volunteers: t

Study Arms:
- Prevnar 13 (Type: ACTIVE_COMPARATOR): 13 valent Pneumococcal Conjugate
- multivalent pneumococcal conjugate formulation 1 (Type: EXPERIMENTAL): multivalent pneumococcal conjugate formulation 1
- multivalent pneumococcal conjugate formulation 2 (Type: EXPERIMENTAL): multivalent pneumococcal conjugate formulation 2

Based on this trial design, predict the completion outcome and termination type (if applicable).